Incyte Corp.

NASDAQ:INCY   3:59:52 PM EDT
75.93
+0.30 (+0.40%)
Products

FDA Approves Lilly And Incyte's Olumiant® (Baricitinib) As First And Only Systemic Medicine For Adults With Severe Alopecia Areata

Published: 06/14/2022 02:03 GMT
Incyte Corp. (INCY) - :fda Approves Lilly and Incyte's Olumiant® (baricitinib) As First and Only Systemic Medicine for Adults With Severe Alopecia Areata.
Lilly Also Expects Regulatory Decisions for Olumiant in Aa in European Union and Japan in 2022.